Ablexis, LLC, a biopharmaceutical company focused on licensing its AlivaMab Mouse technology for antibody drug discovery, has announced a license agreement....
Investment management firm Deerfield has acquired Ablexis, a company that has developed AlivaMab Mouse technology, which is a transgenic mouse platform for human antibody drug discovery.